MitoImmune Therapeutics
MitoImmune Therapeutics is a biotech company in Seoul, South Korea, founded in 2018. It has raised $14.4M across 2 rounds, most recently a $3.9M Series B in September 2023.
Mighty Mitochondria For a Healthier Life
- Headquarters
- Seoul
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- mitoimmune.com
- Total Funding
- $14.4M
- Last Round
- $3.9M Series BSep 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
MitoImmune Therapeutics is a clinical-stage biopharmaceutical company based in Seoul, South Korea, focused on developing novel therapeutics targeting mitochondrial dysfunction and ferroptosis — a form of iron-dependent programmed cell death — in inflammatory and degenerative diseases. The company's proprietary MIT (Mitochondria-targeting Indole-based Therapeutics) Platform serves as the foundation for its lead compound MIT-001, which is in development for oral mucositis in head and neck cancer and blood cancer patients, graft-versus-host disease (GvHD), and neurodegenerative diseases including Alzheimer's disease. MitoImmune also pursues additional indications including Friedreich's Ataxia, leveraging two complementary delivery technologies: BIM (high blood-brain barrier penetration) and PIM (non-CNS targeting). The company is located in Songpa-gu, Seoul, within the Munjeong Hyundai Knowledge Industry Center.
Summary
It lists 11–50 employees. It has raised $14.4M in total across 2 rounds, most recently a $3.9M Series B round in Sep 2023. Investors include KB Investment and IMM Investment.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2023
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mitoimmune-therapeutics"><img src="https://indexed.vc/api/badge/company/mitoimmune-therapeutics" alt="MitoImmune Therapeutics on Indexed.vc" width="260" height="76" /></a>